Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vorolanib
Therapeutic Area : Ophthalmology
Study Phase : Phase I
Sponsor : EyePoint Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details :
Product Name : EYP-1901
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 05, 2022
Lead Product(s) : Vorolanib
Therapeutic Area : Ophthalmology
Highest Development Status : Phase I
Sponsor : EyePoint Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement